https://www.biomarkersmeeting.com/landing daily 1.0 2025-07-09 https://www.biomarkersmeeting.com/scientific-program daily 0.75 2026-03-19 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1548147712157-I53F62PR4QWP59HFSRB2/image-asset.jpeg Scientific Program https://www.biomarkersmeeting.com/contact daily 0.75 2020-09-04 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1548147803810-24CBQ7792XS0GRFNXKJI/image-asset.jpeg Contact https://www.biomarkersmeeting.com/participants daily 0.75 2026-01-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599237232497-5Q0LU5PA7SX4I3STLOV0/IMG_4902.jpg Participants https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599486675311-D6VE596MEC21VEMUOY7K/Adams%2Bphoto.jpg Participants Kirkwood F. ADAMS https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/dfbfcae7-6469-467b-8a55-748caba17c40/Butler_photo.jpg Participants Javed BUTLER https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/b44ad36d-a1b5-44ff-9fea-4d593bab014a/Ferreira_photo.jpg Participants João FERREIRA https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599488381610-EO615RK6NT5ND1I4JL79/Januzzi%2Bphoto.jpg Participants James JANUZZI https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600261280844-ZYD84IUQS97S1RHN81Y5/Lopez+photo.jpg Participants Natalia LÓPEZ https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/7ac2992c-bee0-49b9-b4a7-64e64b0c8d4b/Mentz-2025-front-headshot1.jpg Participants - Make it stand out Robert MENTZ https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/3c52abac-0950-405f-85f2-c5731a6b6ad1/Rossignol+Patrick+photo.jpg Participants Patrick ROSSIGNOL https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599572982893-D90S518FKTI2WDN4D7KX/Verdonschot+photo.jpg Participants Job VERDONSCHOT https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/e790e7ce-ff1c-48ed-b0cd-4cfb5efccf27/SD+Anker+photo.jpg Participants - Make it stand out Stefan ANKER https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/5f3cc08a-00ed-46e4-b859-8da8a8c33808/Cleland+photo.jpg Participants John CLELAND https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/16f8cada-859a-4e39-8cc4-a2173f6589dd/Foto_AGonzalez_Febrero+2019.jpg Participants Arantxa GONZALEZ https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/412916e5-1922-47c9-9f81-ddb78cd5eabe/Lanfear_David_22.jpg Participants David LANFEAR https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/c9afd47d-2cf2-48f1-9bdb-a94222fe38c8/Lumbers+photo.png Participants - Make it stand out Tom LUMBERS https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/bff4590f-20a9-4d0c-9cc7-920f4ea0fb81/IMG_0035.jpg Participants - Make it stand out Wouter OUWERKERK https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/f8f43801-c266-4dd6-89a8-76b4fef0b9a6/Pi%C3%B1a+photo.jpg Participants - Make it stand out Ileana PIÑA https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600433221794-I6DA9FID1OU1NBX7KCT6/Tromp%2Bphoto.jpg Participants Jasper TROMP https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/0638bf0a-e1e4-4a7f-94f1-d963b7faa54c/Capture+d%E2%80%99%C3%A9cran+2024-12-18+%C3%A0+13.49.09.png Participants Faiez ZANNAD https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/4c597a4a-bf5f-4e25-95c9-891dd160d431/Photo_Feriel+Azibani.jpg Participants - Make it stand out Feriel AZIBANI https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/a00192a4-9b3d-4b44-9862-0093edad77ed/Biomarker_meeting_Photo_JustDronkers.jpg Participants - Make it stand out Just DRONKERS https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/e0491c94-ba8a-4ce2-9f89-0351a214b561/Hulsmann+photo.jpg Participants - Make it stand out Martin HÜLSMANN https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/68b4eb52-1757-44fa-adb9-f4260a9784af/Liu+photo.jpg Participants - Make it stand out Peter LIU https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599570947277-221IMDZJRZJ59O2OHA2A/Mebazaa%2Bphoto.jpg Participants Alexandre MEBAZAA https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/a36a2000-0881-49d1-9c55-a3e6e718fe0e/Pinto+photo.png Participants - Make it stand out Yigal PINTO https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/cb56aad8-d49b-495e-9e51-06bc187ce895/bart.jpg Participants - Make it stand out Bart VAN ESSEN https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/efa0643a-e7e9-4934-b873-92c22a888cc5/Voors+photo.jpg Participants - Make it stand out Adriaan VOORS https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/656dea6b-3a63-4fa7-85bd-37a54ad8c24b/Image1.jpg Participants - Make it stand out Karine BOURGEOIS https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/8506edd7-b612-4e24-a4e5-efc578590e65/Muntendam+photo.jpg Participants - Make it stand out Pieter MUNTENDAM https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/2e4be02c-1d1c-4106-af52-864d50b8a3cf/AR1_3164.jpg Participants - Make it stand out Federica GENOVESE https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/0bbecf06-c074-444e-928f-ee1a08d6f099/Christian+Toft+Madsen.jpg Participants - Make it stand out Christian T MADSEN https://www.biomarkersmeeting.com/venue daily 0.75 2019-01-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1548147578322-PI7E5VQ2F3OE4SVIMH27/image-asset.jpeg Venue https://www.biomarkersmeeting.com/home daily 0.75 2026-03-12 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/a2680cdb-860a-4e18-8a3d-3d75c0ce5cb5/anniversary+celebration+of+%281%29.jpg Biomarkers 2026 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599232910012-MESHHL0FWXA5MRSFYB3U/Adams_photo.jpg Biomarkers 2026 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599232907627-S492L48FOY8L3CY1JLWG/Zannad_photo.jpg Biomarkers 2026 https://www.biomarkersmeeting.com/brunnerla-rocca daily 0.75 2020-09-07 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599485718198-6MARYPTAXEMK3ETG43WI/Brunner+La+Rocca+photo.jpg Brunner-La Rocca - Hans-Peter BRUNNER-LA ROCCA - Maastricht, Netherlands Hans-Peter Brunner-La Rocca did is training as cardiologist in Switzerland. Since 20 years, he is clinically and scientifically busy with heart failure, with special focus on personalised approaches to care. 6 years ago, he moved to Maastricht, NL, as professor of cardiology, head of the heart failure clinic and vice chairman of the department of Cardiology. The current research fields in heart failure include biomarkers, co-morbidities, tele-health, care processes and optimisation of care. He authored more than 200 peer-reviewed articles. https://www.biomarkersmeeting.com/butler daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/e6326e09-aa5b-44b5-8ebd-48cf142a64ed/Butler_photo.JPG Butler - Javed BUTLER - Jackson, USA Javed Butler, MD, MPH, MBA, is the President of the Baylor Scott and White Research Institute and Senior Vice President for the Baylor Scott and White Health in Dallas, Texas. He currently holds the Maxwell A. and Gayle H. Clampitt Endowed Chair for research. He is also the Distinguished Professor of Medicine at University of Mississippi in Jackson, Mississippi. Prior to joining Baylor Scott and White Health, he served as the Patrick H. Lehan Chair in Cardiovascular Research, and Professor and Chairman of the Department of Medicine at the University of Mississippi, where he was also Professor of Physiology. Prior to joining the University of Mississippi, he was Charles A. Gargano Professor and Director of the Division of Cardiovascular Medicine and Co-Director of the Heart Institute at Stony Brook University, New York. He had served as the director for heart failure research at Emory University and director of the heart and heart-lung transplant programs at Vanderbilt University prior to that. He received his medical degree from the Aga Khan University and then completed residency training at Yale University, cardiology fellowship and advanced heart failure and transplant fellowships at Vanderbilt University, and cardiac imaging fellowship at the Massachusetts General Hospital at the Harvard Medical School. He has completed Master of Public Health degree from Harvard University and Master of Business Administration from Emory University. Dr. Butler is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure. He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association. Dr. Butler has authored more than 1300 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals. He has been cited numerous times in America’s Best Doctors list. https://www.biomarkersmeeting.com/hlsmann daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599487962044-QOXH3JYWQDMXCZQ1CQBB/46-70016358.jpg Hülsmann - Martin Hülsmann - Vienna, Austria Martin Hülsmann is head of the Heart failure out-patient unit, and the scientific working group of heart failure research of the Medical University of Vienna, Austria. After his studies in Cardiology and Intensive Care Medicine and Internal medicine, he worked as a scientific. A few years later, he became assistant at the Department of Angiology of the MUW. Moreover, he is also a member of the Austrian Society of Cardiology, the Austrian working group of heart failure, the Austrian working group of heart failure… https://www.biomarkersmeeting.com/delles daily 0.75 2020-09-07 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599486501431-9M2DGO1UWTZKCNER1BRP/Delles+photo.jpg Delles - Christian DELLES - Pamplona, UK Dr Christian Delles is Professor of Cardiovascular Prevention and Deputy Director of the Institute for Cardiovascular and Medical Sciences, University of Glasgow. He is an Honorary Consultant Physician with NHS Greater Glasgow & Clyde. He is interested in the initiation and progression of cardiovascular diseases. His research is in the area of vascular biology with oxidative stress and endothelial function as pathogenetic factors of hypertension and other cardiovascular disorders. As such he studies markers for early diagnosis of diabetic nephropathy; the molecular basis of vascular diseases; the pathogenesis and long-term consequences of hypertensive disorders of pregnancy and gestational diabetes; and differences in the pathophysiology of cardiovascular diseases between men and women. Dr Delles serves as Treasurer of the British and Irish Hypertension Society and Honorary Secretary of the Association of Physicians of Great Britain and Ireland. He is a member of national and international grant panels, Associate Editor of Clinical Science and Cardiovascular Research and serves on the editorial board of other leading cardiovascular journals. He has published more than 250 peer reviewed papers. https://www.biomarkersmeeting.com/rossignol daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599489249738-VDNOOQBFXEOMG4V5ZZXH/Rossignol%2BPatrick%2Bphoto.jpg Rossignol - Patrick ROSSIGNOL - Monaco, Monaco Patrick Rossignol, MD, PhD, is professor of Therapeutics, Nephrologist and Vascular medicine specialist, Deputy Director of Nancy Plurithematic Clinical Investigation center (CIC)-Inserm. He has participated/is participating in several EU FP6-7 programs (Ingenious Hypercare: Coord A; Zanchetti; MEDIA: Coord: W. Paulus ; HOMAGE & FIBROTARGETS : Coord F. Zannad , Nancy CIC). He is coordinating a French network of excellence endorsed by F-CRIN (French Clinical research Infrastructure Network, the French affiliate of ECRIN/ERIC: Cardiovascular and Renal Clinical Trialists (INI-CRCT www.inicrct.org) since 2014. He is coordinating the University Hospital “French Government Investment for the Future” Fighting Heart Failure program (2016-2020). He is the PI of the ongoing largest double blind (spironolactone vs. placebo) academic cardiovascular outcome randomized controlled trial in hemodialysis (ALCHEMIST: ClinicalTrials.gov Identifier: NCT01848639) and steering committee member of several international randomized clinical trials. He is a EURECA-m (cardiorenal working group of ERA-EDTA: The European Nephrology Dialysis Transplantation Association) member since its creation in 2009 and got elected as board member (2013-2016) and he is now serving as scientific advisor. Since 2016 is a Heart Failure Association of the European Society of Cardiology “Translational” and “Cardiorenal” board member. He is CardioRenal cofounder. https://www.biomarkersmeeting.com/girerd daily 0.75 2020-09-07 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599487453071-OJKKEEYLLOSM6KZL3B0T/Girerd+photo.JPG Girerd - Nicolas GIRERD - Nancy, France Pr Nicolas Girerd, MD, PhD, is the deputy director of Nancy Clinical Investigation Center. He is a Professor of Therapeutics at the Nancy School of Medicine of the Lorraine University. He works as a clinical cardiologist specialized in Heart failure and has a PhD in biomathematics/biostatistics. He has a broad experience in the field of data analysis (>220 publications, google h-index 30, WOS h-index 25). He is currently the PI of several studies focused on congestion quantification in heart failure and/or acute dyspnoea (especially using Lung Ultrasound): AHF-CORE, AHF-CODE, EMERALD and the AMBUSH trial. He is also the methodologist - biostatistician of several randomized clinical trials in the field of heart failure and/or MRA therapy (HYPO-ECMO, EPURE TRANSPLANT, LEVOHEARTSHOCK). His current research interests are mainly focused on the quantification and treatment of congestion in acute and chronic heart failure. He also has a special interest in machine-learning based methods, especially for the prediction of treatment effect and the identification of phenotypes within heterogenous populations. https://www.biomarkersmeeting.com/januzzi daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599488236654-DPRK8NAL0F37L7FND78B/Januzzi+photo.jpg Januzzi - James JANUZZI - Boston, USA Dr. James Januzzi is currently the Adolph Hutter Professor of Medicine at Harvard Medical School and a staff member in the Cardiology Division of the Massachusetts General Hospital. He is also the Chief Scientific Officer at the Baim Institute for Clinical Research, where he serves as the C. Michael Gibson Chair. Dr. Januzzi’s research work has contributed greatly to the understanding of cardiac biomarker testing, where his studies have set international standards for biomarker use for diagnosis, prognosis, and management of heart failure as well as acute coronary syndromes. He has participated in clinical trials of therapeutics for heart failure, obesity, diabetes, chronic coronary artery disease and acute coronary syndromes. As of April 2025, he has published more than 1000 manuscripts, book chapters and review articles, and has edited six textbooks. He has an H-index of 150, having been cited nearly 140000 times; he is among the top 1% most cited authors in the world and was presented the 2025 American College of Cardiology Distinguished Clinical Researcher Award. He has been involved in publishing for nearly 20 years. Presently, he is a Deputy Editor at the Journal of the American College of Cardiology. https://www.biomarkersmeeting.com/ferreira daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599487189898-ST97TWT828VKQ472186J/Ferreira_photo.png Ferreira - João FERREIRA - Porto, Portugal João Ferraira is a cardiovascular physician (hypertension, co-morbidities and heart failure with preserved ejection fraction clinics), university teacher and researcher at the university of Lorraine and Nancy hospital in France. He is also an invited professor by the university of Porto, Portugal, and a visiting fellow at the university of Glasgow. His main research interests are all things around mineralocorticoid receptor antagonists, fibrosis, health quality and outcomes, clinical trials, biostatics and trial methodology, and implementation science in axis that incorporate the availability, accessibility, affordability, and acceptability of treatments that may improve people`s life`s. https://www.biomarkersmeeting.com/zannad daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/4ec2e71b-1957-44b4-814a-ae28256de959/Capture+d%E2%80%99%C3%A9cran+2024-12-18+%C3%A0+13.49.09.png Zannad - Faiez ZANNAD - Nancy, France MD, Cardiologist, PhD Clinical Pharmacology (Université de Lorraine, Nancy, Université Claude Bernard, Lyon, France and Oxford MRC, UK). Emeritus Professor of Therapeutics at the Université of Lorraine, Past Director of the Inserm Clinical Investigation Center at Institut Lorrain du Coeur et des Vaisseaux, Nancy, France. 2019 Eugene Braunwald Scolar at Harvard Medical School. As a clinical trialist Dr Zannad has significantly contributed to building most of the trial-based evidence supporting modern heart failure drug therapy, including mineralocorticoid receptor antagonists, beta-blockers, and SGLT2inhibitors, as well as the management of major comorbid conditions in heart failure, such as sleep-disordered breathing, autonomic nervous dysfunction, diabetes, hyperkalaemia, and chronic kidney disease. As a clinical pharmacologist, he developed expertise in biomarker and proteomic science, exploring the mechanisms of action of heart failure drugs. Dr Zannad served as Chairman of the French Society of Hypertension and of the Working Group on Pharmacology and Drug Therapy of the European Society of Cardiology (ESC). He is the founder of the Global CardioVascular Clinical Trialists (CVCT) Forum and Workshop, a global community and think tank dedicated to the science of clinical trials, with meetings in Paris, Washington DC, Asia and the Middle East. He has also Co-founded The Transatlantic Heart Failure Biomarker Working Group, and MOSAIC an multi-organ multispecialty imitative promoting the concept of Cardiac Liver Metabolism (CLM), integrating the clinical development of combinatorial agents targeting CV and MASLD at once. Dr Zannad is a Highly Cited Researcher Award Recipient in the field of Clinical Medicine. He received the 2014 European Society of Hypertension Paul Milliez Award, the 2017 ESC-Heart Failure Association Lifetime Achievement Award and the 2022 Heart Failure society of Americas international Honorary Fellowship Award. https://www.biomarkersmeeting.com/mentz daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/761beea9-4097-405f-988c-2801bdc6d558/Mentz-2025-front-headshot1.jpg Mentz - Robert MENTZ - Durham, USA Dr. Robert J. Mentz, MD is an Associate Professor of Medicine with Tenure and Chief of the Heart Failure Section at Duke University. He is Co-Editor-in-Chief of the Journal of Cardiac Failure – the official journal of the Heart Failure Society of America. Robert spends his clinical time at Duke University Hospital assisting with the care of patients with heart failure, cardiac transplants and ventricular assist devices. He is a leading clinical trialist in both traditional and pragmatic studies. He was the clinical lead for the HEART-FID trial of IV iron in 3065 participants. He served as Co-PI for the NIH-funded TRANSFORM-HF pragmatic trial of loop diuretics in 2,859 patients with heart failure and PI of the PARAGLIDE-HF trial of sacubitril/valsartan in acute HFpEF. He has published >600 manuscripts—many with current or former trainees as the first author. He has expertise in trial design and execution that supports the inclusion of diverse participants. He is a leader in site engagement with efficient recruitment that streamlines clinical studies while optimizing data quality. He is a Co-PI for the FDA’s Research Triangle CERSI (Center of Excellence in Regulatory Science and Innovation). He is an established mentor for medical students, residents and fellows and was the recipient of the 2021 Clinical Research Mentoring Award from the Duke School of Medicine and the W. Proctor Harvey Award from the American College of Cardiology. https://www.biomarkersmeeting.com/schiller daily 0.75 2020-09-07 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599489980146-9FBEIQRF7DDG6YJAH1A1/Schiller+photo.jpg Schiller - AnnaLotta SCHILLER - Sweden Regional manager for Southern Europe & France. AnnaLotta has a Ph.D. in molecular biology and nutrigenomics and more than 25 years’ experience as a life science professional with previous roles in research & development, application support, marketing, sales and product management. https://www.biomarkersmeeting.com/adams daily 0.75 2020-09-07 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599483834699-GICZ88UXIM4O6KEDQNUD/Adams+photo.jpg Adams - Kirkwood F. ADAMS - Chapel Hill, USA Kirkwood F. Adams Jr., M.D., is Associate Professor of Medicine and Radiology in the Division of Cardiology, University of North Carolina at Chapel Hill, where he founded and for many years directed the UNC Heart Failure Program and served as the first transplant cardiologist for two decades. Dr. Adams has been involved in more than 130 completed grant- and industry-funded research projects, and he is currently leading or participating in multiple drug development trials, several registry and database studies, and NIH/NHLBI-funded trials. Dr. Adams is the principal investigator for the national multicenter database group, UNITE-HF, which focuses on registries of patients with heart failure. In addition to drug development for acute and chronic heart failure, his current research interests are heavily focused on personalized medicine with ongoing projects related to novel biomarkers for heart failure, pharmacogenomics of heart failure therapeutics, and biomarker guided therapy for improving outcomes in CHF. He is very actively involved on the Executive Committee for the NHLBI sponsored trial of NT- proBNP guided therapy known as the GUIDE-IT Trial. https://www.biomarkersmeeting.com/lanfear daily 0.75 2025-04-25 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/412916e5-1922-47c9-9f81-ddb78cd5eabe/Lanfear_David_22.jpg Lanfear - David LANFEAR - Detroit, USA Dr. David E. Lanfear is currently working at Department of Internal Medicine, Henry Ford Hospital, Detroit MI, 48202, USA. His research interest includes Cardiology and Cardiac Researches. He has authored several research articles/books related to Heart Disease, Cardiomyopathy, Heart failure, Cardiac Therapy. For Journal of Clinical & Experimental Cardiology, he has authored Relationship of Loop Diuretic Dosing and Acute Changes in Renal Function during Hospitalization for Heart Failure https://www.biomarkersmeeting.com/diez daily 0.75 2020-09-08 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599568577032-EXWCJGAWVRFFD3C49CMF/Diez+photo.jpg Diez - Javier DIEZ - Pamplona, Spain Prof. Díez graduated in Medicine at the Medical School of the Autónoma University of Madrid, in 1976. He holds a certificate of Nephrology and Internal Medicine at the University Clinic. He next became a research fellow at the Necker Hospital and at the Brigham and Women’s Hospital, where he trained in cardiovascular biology. In 2009 he was appointed as Full Professor of Medicine of the University of Navarra. At present, he is the Director of the Program of Cardiovascular Diseases in the same Center, Scientific Director of the Department of Nephrology and Consultant and Head of Research in the Department of Cardiology and Cardiac Surgery, both at the University of Navarra Clinic. During the last decades his main research interest has been focused on the mechanisms of myocardial fibrosis involved in non-ischemic heart diseases and heart failure. In addition, his work has been also aimed to identify circulating biomarkers of myocardial fibrosis potentially useful in the cardiac assessment and handling of cardiac patients. https://www.biomarkersmeeting.com/cleland daily 0.75 2020-09-08 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599568040855-LLV48YPJJLUHCRK07B3N/Cleland+photo.jpg Cleland - John CLELAND - Glasgow, UK He is a leading international researcher in heart failure, focusing on improving diagnosis, management and monitoring, and has led large, international clinical trials to study treatments. He also conducted one of the earliest large trials of home telemonitoring for heart failure and continues to promote innovations in this field. Professor Cleland qualified at the University of Glasgow in 1977. Shortly after, he was appointed as a senior registrar. Between 1986 and 1994, he was a senior lecturer in cardiology and honorary consultant cardiologist at St Mary’s Paddington and Hammersmith Hospital, London. In 1994, Professor Cleland was awarded a senior research fellowship from the British Heart Foundation, and so transferred to the Medical Research Council’s research initiative in heart failure. He joined Royal Brompton & Harefield NHS Foundation Trust from the University of Hull, where he was appointed foundation chair of cardiology in 1999. https://www.biomarkersmeeting.com/liu daily 0.75 2020-09-08 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599569451863-R2YMIHOTV6ADQLK8D1YE/Liu+photo.jpg Liu - Peter LIU - Ottawa, Canada Dr. Peter Liu is the Chief Scientific Officer and Vice President, Research, of the University of Ottawa Heart Institute, and also Professor of Medicine and Physiology at the University of Toronto and University of Ottawa. He was the former Scientific Director of the Institute of Circulatory and Respiratory Health at the Canadian Institutes of Health Research, the major federal funding agency for health research in Canada. Prior to that role, he was the inaugural Director of the Heart & Stroke/Lewar Centre of Excellence in Cardiovascular Research at University of Toronto. He received his MD degree from University of Toronto, and postgraduate training at Harvard University. His laboratory investigates the causes and treatments of heart failure, role of inflammation and identification of novel biomarkers and interventions in cardiovascular disease. He has published over 300 peer reviewed articles in high impact journals, and received numerous awards in recognition of his research and scientific accomplishments. His publications have received over 28,000 citations to date, and has an H-index of 78. He has chaired or co-chaired scientific sessions of the Heart Failure Society of America, International Society of Heart Research and Human Proteomic Organization, amongst others. He reviews programs for major international funding agencies. He is also champion for knowledge translation, integrating the cardiovascular prevention guidelines and healthy heart policy in Canada and internationally. https://www.biomarkersmeeting.com/de-filippi daily 0.75 2020-09-08 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599568342287-APSGY8GQ4SPBTY2PN23M/Defilippi%2Bphoto%2B1.jpg De Filippi - Christopher DE FILIPPI - Falls Church, USA Dr. Christopher R. Defilippi is a cardiologist in Falls Church, Virginia and is affiliated with multiple hospitals in the area. He has been in practice for more than 20 years. He diagnoses and treats heart disease, such as congenital heart defects, coronary artery disease, heart rhythm and heart failure. He is also affiliated with Sinai Hospital of Baltimore, University of Maryland Medical Center, Veterans Affairs Maryland Health Care System-Baltimore Division and Inova Fairfax. https://www.biomarkersmeeting.com/gonzalez daily 0.75 2025-04-25 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/b70288c0-31a3-4b79-ae42-0420c71d6c50/Foto_AGonzalez_Febrero+2019.jpg Gonzalez - Arantxa GONZALEZ - Pamplona, Spain Aranxta Gonzalez works as staff researcher in the Division of Cardiovascular Sciences. She is also an Associate Professor of the School of Medicine. Additionally, she is a researcher from the Ramón y Cajal Program (2010) from the Ministry of Science and Innovation (Spain). Her studies are focused in the analysis of the mechanisms involved in myocardial remodelling, which in turn plays a major role in the evolution of heart failure, as well as in the search for non-invasive circulating biomarkers of remodelling. https://www.biomarkersmeeting.com/pinto daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599571542512-JWC2LN9S64A9NZ878CQE/Pinto+photo.png Pinto - Yigal PINTO - Amsterdam, Netherlands Professor Y.M. Pinto has been named Professor of Molecular Biology of Heart Failure in the Faculty of Medicine of the University of Amsterdam. Yigal Pinto's research focuses on heart failure. Between 2001 and 2007, Pinto worked as a cardiologist at the Medical Hospital in Maastricht. Prior to this, he worked at the UMC Groningen. Pinto was appointed Professor in 2005 at the Interuniversity Cardiology Institute of the Netherlands (ICIN) of the Royal Netherlands Academy of Arts and Sciences (KNAW). He is a member of both the Young Academy and the Council for Medical Sciences of the KNAW. https://www.biomarkersmeeting.com/snider daily 0.75 2020-09-08 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599574340058-123LRREBL8O0LFFFDN5F/Snider+photo.jpg Snider - James SNIDER - USA James joined Critical Diagnostics as President in 2005, shortly after the company's formation. He has extensive experience in product development and operations in both startup and large companies. Prior to joining Critical Diagnostics, James was the Executive Vice President of Business & Operations for IntelligentMD, an early-stage medical device company that focuses on the essential elements of disease diagnostics and therapeutic intervention. Previously, he spent eight years in a series of marketing and product development positions at Applied Biosystems (ABI). James holds a B.S. in chemistry from Grand Valley State University and a Ph.D. in chemistry from the University of South Carolina. https://www.biomarkersmeeting.com/lumbers daily 0.75 2020-09-08 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599570620209-L7DRV8EDIY1EKEN1I0IB/Lumbers%2Bphoto.jpg Lumbers - Tom LUMBERS - London, UK Tom Lumbers is UKRI Rutherford Fellow at Health Data Research UK, co-lead Genomics Group at the UCL Institute of Health Informatics, Honorary Consultant Cardiologist at Barts Heart Centre, and a Visiting Scientist at the Broad Institute of Harvard and MIT. He received his Ph.D. in Molecular Biology at Imperial College London and subsequently completed training in Genetic Epidemiology at University College London. His cardiology training was at Barts Heart Centre and his clinical interests include noninvasive general cardiology, heart failure, and cardiovascular genetics. Tom’s research focuses on defining the genetic architecture of heart failure and left ventricular dysfunction to generate insights into causal factors and molecular disease mechanisms. He coordinates the HERMES Consortium (hermesconsortium.org), an international collaboration in heart failure genetics, and is co-lead of the phenotype working group at BigData@Heart, an EU public-private consortium (bigdata-heart.eu). He has received grant funding from the Medical Research Council, National Institute of Health Research, American Heart Association Precision Medicine Initiative. https://www.biomarkersmeeting.com/mebazaa daily 0.75 2020-09-08 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599570893038-AHAQ5B00JNFXTMMGR1U7/Mebazaa%2Bphoto.jpg Mebazaa - Alexandre MEBAZAA - Paris, France Alexandre Mebazaa, MD, PhD, FESC, is Professor of Anaesthesiology and Critical Care Medicine at the Hôpital Lariboisière, University Paris 7, France. His research interests include mechanisms of contractile impairment during acute heart failure and global studies on biomarkers in acute heart failure. He acted as member or Chair of several Steering Committees including SURVIVE, COMPOSE, TRUE-HF. He is also involved in several European and global registries on circulatory failure. He has authored or co-authored more than 200 papers and is Lead-Editor of the Acute Heart Failure textbook. Dr Mebazaa also serves as the Chair of Department of Anesthesiology and Critical Care in Paris. https://www.biomarkersmeeting.com/verdonschot daily 0.75 2020-09-08 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599572915666-U86DW8RJJVOVWY0MZNJ5/Verdonschot%2Bphoto.jpg Verdonschot - Job VERDONSCHOT - Maastricht, Netherlands Job Verdonschot finished his bachelor molecular life sciences in 2010 at Maastricht University. With the ambition to combine research and clinic in the future, he combined a research master Cardiovascular Biology and Medicine with a bachelor in medicine. For his senior internship he joined the clinical group of Prof. Dr. S. Heymans under daily supervision of Drs. Mark Hazebroek to focus on the viral, genetic and metabolic triggers on the development of dilated cardiomyopathy. After multiple internships at the department of clinical genetics at the Academic hospital of Maastricht, he was granted a Kootstra Talent Fellowship on a proposal focused on increasing the diagnostic yield of genetic diagnostics in patients with a dilated cardiomyopathy. His main interest is in (clinical) cardiogenetics, the unraveling of new disease-causing genes and the determination of the pathogenicity of mutations in patients with dilated cardiomyopathy. https://www.biomarkersmeeting.com/muntendam daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599574648047-VQE0GP021XYZ68GDAVA8/Muntendam+photo.jpg Muntendam - Pieter MUNTENDAM - SQ Innovation - USA Pieter Muntendam is a trained physician who has devoted his career to medical innovation by developing novel pharmaceuticals, medical devices, and services for payers and employers to reduce the burden of common conditions such as cardiac disease, diabetes and asthma. Dr. Muntendam is the inventor of a novel galectin-3 assay that was approved for clinical use by the FDA in 2010 for use in patients with heart failure. He has raised over $250M in public and private funding as CEO of early-stage companies. https://www.biomarkersmeeting.com/pia daily 0.75 2020-09-08 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599571247972-9WR569W7VUVHCZE2MSZS/Pi%25C3%25B1a%2Bphoto.jpg Piña - Ileana L. PIÑA - Detroit, USA Ieana L. Piña, MD, MPH is a Professor of Medicine, Epidemiology & Population Health at the Albert Einstein College of Medicine in the Bronx, NY. Dr. Piña also serves as advisor/consultant to the Food and Drug Administrations’ (FDA) Center for Devices and Radiological Health and their section of Epidemiology. Dr. Piña earned her undergraduate degree in Chemistry from the University of Miami in Florida. She completed her medical degree and cardiology fellowship at the University of Miami School of Medicine, an internal medicine residency at the University of South Florida Tampa, where she was Chief Resident, and fulfilled a surgery internship at the University of Miami Hospitals and Clinics. She earned a master's degree in public health from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Piña’s research interests include transition of care in heart failure patients, and the role of natriuretic peptide-guided management for patients hospitalized for heart failure, biomarkers of myocardial stress and fibrosis in chronic heart failure, and the clinical implications of chronic heart failure phenotypes. She is the author/co-author of more than 100 publications. https://www.biomarkersmeeting.com/voors daily 0.75 2020-09-08 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599573284680-DFX36QT9GPNLB1OLKDFF/Voors+photo.jpg Voors - Adriaan VOORS - Groningen, Netherlands Adriaan Voors completed medical school in 1994 in Utrecht, the Netherlands. In 1997, he defended his PhD thesis entitled “Risk Factors, Endothelial Function and Clinical outcome after Coronary Bypass Surgery”. He completed his training in internal medicine and in cardiology. In July 2003, he started working as a Cardiologist, and became staff member of the department of cardiology of the University Medical Center Groningen. Currently, he is director of the Heart Failure Clinic and director of the Department of Echocardiography of the University Medical Center Groningen. https://www.biomarkersmeeting.com/thum daily 0.75 2020-09-08 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599572069902-SU92BM0Z2XSZ17B7LIP9/Thum+photo.jpg Thum - Thomas THUM - Hannover, Germany Dr Thum graduated from Hannover Medical School, Germany, and initially worked in the field of Molecular Cardiology and Clinical Pharmacology. In 2009, Dr Thum became Professor and Director of the Institute of Molecular and Translational Therapeutic Strategies, where he coordinates multiple approaches to better diagnose and treat various diseases using non-coding RNA molecules. https://www.biomarkersmeeting.com/live-1 daily 0.75 2020-09-09 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599670347889-FKQL3T1S0JPNVHKEGF9R/IMG_4832.jpg Welcome to Biomarkers 2020 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599669992005-K8GLT3XAAR0MIN3C3HUF/IMG_4835+2.jpg Welcome to Biomarkers 2020 LIVE EVENT https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599670196804-X950W3NORCW0AL9KYSQP/image-asset.jpeg Welcome to Biomarkers 2020 Scientific Program https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599670109799-2A2H5SJST0KQJNZXPXMZ/IMG_4910.jpg Welcome to Biomarkers 2020 Participants https://www.biomarkersmeeting.com/latini daily 0.75 2020-09-16 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600258751369-GDAAWIZ1V5BJOJY04R7E/5d0b99352ab90ce25cf47c1d_roberto-latini-istitutomarionegri.jpg Latini - Roberto LATINI - Milan, Italy Roberto Latini graduated in Medicine and Surgery in 1978 at the University of Milan, he then specialized in Pharmacological Research at the Mario Negri Institute in Milan. Since 1990 he has been Head of the Cardiovascular Clinical Pharmacology Laboratory of the Mario Negri Institute, where since March 2013 he has been Director of the Cardiovascular Research Department. His fields of professional interest include: Mechanisms of cardiac damage resulting from acute myocardial infarction, in particular those related to neurormonal activation. Use of stem cells to repair the structural and functional damage resulting from myocardial infarction in the small rodent. Biohumoral studies in large trials in heart failure and atrial fibrillation in search of new markers of prognosis and response to treatment. https://www.biomarkersmeeting.com/ballagi daily 0.75 2020-09-11 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599833121797-Q2I8NMJXMAUQ4VR9YZDF/Ballagi%2Bphoto.jpg Ballagi - Andrea BALLAGI - Sweden Dr. Ballagi is currently Director of Commercial Operations at Olink Bioscience. She has received MD, PhD, MBA degrees from Semmelweis School of Medicine, Budapest, Ludwig Institute for Cancer Research Uppsala, Sweden, Uppsala University. She is specialized in Bio-Technology. https://www.biomarkersmeeting.com/lopez daily 0.75 2020-09-17 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600332387011-YM3OAJRVSEWM4VC7VNZ0/Lopez+photo.jpg Lopez - Natalia LÓPEZ - Pamplona, Spain Dr. Natalia López-Andrés has dedicated her scientific career to Biology, graduating from this degree at the University of Navarra. She decided to specialize in cardiovascular sciences doing the doctorate at the Division of Cardiovascular Sciences of the University of Navarra, obtaining the PhD in 2006. She holds a postdoctoral position at the Division of Cardiovascular Sciences in the Centre for Applied Medical Research from 2006 to 2008. During these years she worked with a multidisciplinary research team specialized in the study of heart failure. This expertise enabled Natalia Lopez-Andrés to occupy a postdoctoral position at the INSERM, in the unit U961, from 2008 until January 2013. This unit focuses its research in the mechanisms of action and the diagnostic and therapeutic aspects applied to the field of cardiovascular stiffness-fibrosis and hypercoagulability. In 2013, she obtained the competitive Miguel Servet contract that allowed her to build a new research group in Navarrabiomed, the Translational cardiovascular research group, in the interface between clinical and basic research. Over the past 7 years her laboratory has investigated the role of Aldosterone/mineralocorticoid receptor and its biotargets in myocardial, vascular and renal fibrosis. Moreover, the program of her group focuses on the study of heart valve diseases. The Program is part of the “Cardiovascular and Renal Diseases Area” of the Health Research Institute of Navarra (IdiSNA). Dr. Natalia Lopez-Andrés is regularly invited as speaker to many international meetings and congresses. She is author or co-author of 70 publications in international journals. As part of her research career, Dr Natalia López-Andrés has effectively developed contacts and collaborations in other countries and universities to enhance her knowledge and capabilities. Dr. López-Andrés participated as a principal investigator in the European FP7 project Fibrotargets, as a work package leader in the COST action ADMIRE and as principal investigator in national (FIS 2015 and FIS 2018) and regional projects (Salud and Industria, Gobierno de Navarra). Moreover, Dr López-Andrés leaded one project supported by G3 Pharmaceuticals (Boston). https://www.biomarkersmeeting.com/bourgeois daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/4f2d7119-ab98-44d5-a4ad-1292d1900825/Image1.png Bourgeois - Karine BOURGEOIS - 4TEEN4, Germany Karine Bourgeois is a creative and self-motivted biochemist with 9+ years of experience in structural biology, protein biochemistry and cell culture. She has an industrial project management experience. She is finding result-orientated solutions within customer-defined timelines and supports 6 new joint projects in the last 18 months. Her demonstrated time management and organizational skills lead her to the completion of 5 projets and 12 publications during 3,5 years of postdoctoral research funded by personally-secured grants. She is an excellent relationship builder, working well in interdisciplinary and multicultural team settings. She works closely with cross-functional industry experts and builds international collaborations. https://www.biomarkersmeeting.com/grundberg daily 0.75 2020-09-18 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600421220430-J70WWI62JPS4RE4OTEN1/Grundberg+photo.jpg Grundberg - Ida GRUNDBERG - Sweden Ida grew up in the northern part of Sweden before moving to Uppsala to pursue her PhD studies. She went on to receive her PhD in Molecular Medicine at Uppsala University from the research group which developed Olink’s key technology and founded Olink. She continued as senior scientist at Olink for commercialization of the patented technology developed during her PhD. Following the market release, she joined the commercial side and in 2015, she transferred to head of the U.S. market entry and moved to Boston. Olink has now grown into a global company, and Ida recently took on the pole as CSO, leading the global Scientific Affairs team at Olink. https://www.biomarkersmeeting.com/tromp daily 0.75 2020-09-18 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600433050867-97CNTPVJ0STQAZB60BGM/photo_Jasper-Tromp_new.jpg Tromp - Jasper TROMP - Groningen, Netherlands Jasper Tromp is a medical doctor (MD) who completed his PhD in Medicine (Cum Laude/Highest distinction) with a strong interest in global health and big data analytics. He is currently a post-doctoral fellow at the National Heart Centre Singapore, Duke-NUS medical school and co-director of the "Cardiovascular Clinical Trial Data Management Centre" at the National Heart Centre. He manages and spearheads several international collaborations with academia and industry which have led to publications in top tier journals including Journal of the American College of Cardiology, Circulation, European Heart Journal and Lancet Global Health. https://www.biomarkersmeeting.com/2020evaluation daily 0.75 2020-09-23 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600539035461-V2Y6KZL45YH6TVYFB1KI/image-asset.jpeg 2020 Evaluation https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600538682520-2N0LH9V446WSFUK7IEDZ/platform.png 2020 Evaluation - Rate your experience https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600545013170-6HFGOA6W1T6SCT7TVDJK/Session+6.png 2020 Evaluation - THANK YOU! https://www.biomarkersmeeting.com/2021 daily 0.75 2020-12-11 https://www.biomarkersmeeting.com/prerecording daily 0.75 2021-09-08 https://www.biomarkersmeeting.com/resources daily 0.75 2021-09-08 https://www.biomarkersmeeting.com/participants-1 daily 0.75 2021-09-16 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599237232497-5Q0LU5PA7SX4I3STLOV0/IMG_4902.jpg Participants (Copy) https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599486675311-D6VE596MEC21VEMUOY7K/Adams%2Bphoto.jpg Participants (Copy) Kirkwood F. ADAMS https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599568164626-NGVV0NYDNJQYX14GM2DC/Cleland+photo.jpg Participants (Copy) John CLELAND https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599569055867-BR8452ID4ES8AICIPOPN/Diez%2Bphoto.jpg Participants (Copy) Javier DIEZ https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599569971454-53GWNQAYBHSXPS3Q0EN5/Gonzalez%2Bphoto.jpg Participants (Copy) Aranxta GONZALEZ https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599569035978-UKPYWJT20WD7CL3OCI2M/Lanfear%2Bphoto.jpg Participants (Copy) David LANFEAR https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600261280844-ZYD84IUQS97S1RHN81Y5/Lopez+photo.jpg Participants (Copy) Natalia LÓPEZ https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599488617560-O5HLOI5CPGZJ4PIRCVD7/Mentz%2Bphoto.jpg Participants (Copy) Robert MENTZ https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599489272603-A6PE1HILU2LD5STBF7FJ/Rossignol+Patrick+photo.jpg Participants (Copy) Patrick ROSSIGNOL https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599572982893-D90S518FKTI2WDN4D7KX/Verdonschot+photo.jpg Participants (Copy) Job VERDONSCHOT https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599486704617-1OQ1060Y7MPYYDKY7ZII/Brunner%2BLa%2BRocca%2Bphoto.jpg Participants (Copy) Hans-Peter BRUNNER-LA ROCCA https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599568510476-6KBHXH09AGQAUYK8UHM1/Defilippi%2Bphoto%2B1.jpg Participants (Copy) Christopher DE FELIPPI https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599487294881-ZDLK9628KS86SIWPEDTS/Ferreira_photo.jpg Participants (Copy) João FERREIRA https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599488045590-DD7W5LXVSKC0PALLP550/46-70016358.jpg Participants (Copy) Martin HÜLSMANN https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600258200407-KOA5PUZXHJBI6TIH4PB7/5d0b99352ab90ce25cf47c1d_roberto-latini-istitutomarionegri.jpg Participants (Copy) Roberto LATINI https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599570691941-JNJNV2WEA1YNMVMJSIME/Lumbers+photo.png Participants (Copy) Tom LUMBERS https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599571310945-YS6CWTCO3LTGJRQ9FL09/Pi%C3%B1a+photo.jpg Participants (Copy) Ileana N. PIÑA https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599572136021-UTC29KPYGRKVDDA5SBUY/Thum+photo.jpg Participants (Copy) Thomas THUM https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599573315088-L9QQFL4Y790JNR84VG41/Voors+photo.jpg Participants (Copy) Adriaan VOORS https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599486890832-A5PAOBCWF5JIFAOC85CR/Butler%2Bphoto.jpg Participants (Copy) Javed BUTLER https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599486992063-4EHXZQDJHH85JVDL0M9H/Delles%2Bphoto.jpg Participants (Copy) Christian DELLES https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599487551888-JO3OUU9C0NYW62C9815X/Girerd%2Bphoto.jpg Participants (Copy) Nicolas GIRERD https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599488381610-EO615RK6NT5ND1I4JL79/Januzzi%2Bphoto.jpg Participants (Copy) James JANUZZI https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599569494412-GA3655HSKQEBPGCU2HQ8/Liu%2Bphoto.jpg Participants (Copy) Peter LIU https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599570947277-221IMDZJRZJ59O2OHA2A/Mebazaa%2Bphoto.jpg Participants (Copy) Alexandre MEBAZAA https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599571646977-9ISAPQWO3L4K5W86LVCC/Pinto%2Bphoto.jpg Participants (Copy) Yigal PINTO https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600433221794-I6DA9FID1OU1NBX7KCT6/Tromp%2Bphoto.jpg Participants (Copy) Jasper TROMP https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599489801191-WT902FRK1QV3UYF1TI7Y/title-1576680650.jpg Participants (Copy) Faiez ZANNAD https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600097563127-58TVI97KV02V62N3MQ17/Ballagi%25252Bphoto.jpg Participants (Copy) Andrea BALLAGI https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600419618671-6NHFPUX1APV0XJCXACRC/Bourgeois%2Bphoto.jpg Participants (Copy) Karine BOURGEOIS https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600261758931-NH8H07TCU0GKSAG3RQUP/Grundberg+photo.jpg Participants (Copy) Ida GRUNDBERG https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600095471879-9MFUMNR0DCL9JPI5XRMB/Muntendam%2Bphoto.jpg Participants (Copy) Pieter MUNTENDAM https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1599574400057-LN960KIMOLI53CPLR3BF/Snider%2Bphoto.jpg Participants (Copy) James SNIDER https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600095489999-1IZ9EQ17ML6JHXIB9482/Schiller%2Bphoto.jpg Participants (Copy) AnnaLotta SCHILLER https://www.biomarkersmeeting.com/information daily 0.75 2023-09-20 https://www.biomarkersmeeting.com/evaluation daily 0.75 2021-10-02 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600539035461-V2Y6KZL45YH6TVYFB1KI/image-asset.jpeg Evaluation https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1633190737223-DEJZNCRGP0DFFN9Z7NOK/Capture+d%E2%80%99%C3%A9cran+%28352%29.png Evaluation - Rate your experience https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1600545013170-6HFGOA6W1T6SCT7TVDJK/Session+6.png Evaluation - THANK YOU! https://www.biomarkersmeeting.com/registration daily 0.75 2024-08-13 https://www.biomarkersmeeting.com/2022 daily 0.75 2022-11-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1669135476544-YLK6ILS3Y86KLR52S04F/IMG_9861.jpg 2022 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1669135461877-JWQWDGPFGO8PAH9MF64Q/IMG_9889.jpg 2022 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1669135451487-I6F9DTNOTZUK22VZ7RWN/IMG_9884.jpg 2022 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1669135428388-W4MBMVRT8SCJ14OYMW34/IMG_9869.jpg 2022 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1669135428701-08WUU88NR0LBVOEU3VEJ/IMG_9871.jpg 2022 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/1669135441575-JAVVABYROINPJHSLP48E/IMG_9873.jpg 2022 https://www.biomarkersmeeting.com/anker daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/33fbd6fd-a719-45c5-87f8-3658f122d0d5/SD+Anker+photo.png Anker - Stefan ANKER - Berlin, Germany Stefan D. Anker is Professor of (Tissue)Homeostasis in Cardiology & Metabolism (W3) at Charité University Medicine Berlin (from June 2017). He studied medicine at Charité, completed his clinical training in Germany and the UK, and obtained M.D. (1993, Charité), and Ph.D. degrees (1998, National Heart & Lung Institute, Imperial College London/UK). He was Professor of Cardiology & Cachexia Research (W2) at Charité (2002- 14), and Professor of Innovative Clinical Trials (W3) in Göttingen (2014-17). Dr. Anker has authored more than 1,300 articles (total citations: >345,000, h-index: 221, papers with >500 citations: 97; source: GoogleScholar, 18. April 2025) and was named Highly Cited Researcher 2015–2023. For his work Dr. Anker has won several prizes, including the 2018 Copernicus Prize of German DFG & Polish FNP. Dr. Anker was awarded a Doctor honoris causa of Medical University Wroclaw / Poland (October 2020) and of Semmelweis University Budapest / Hungary (November 2021). Dr. Anker obtained a number of fellowships & grants, incl. from the NIH and the EU. He received grants for several IITs (3 currently running) from DZHK Germany & several industries. Dr. Anker was Vice President of the European Society of Cardiology (ESC, 2016-18), serving on the Board 2012-2018. Dr. Anker was President of the Heart Failure Association (HFA) of the ESC (2012-14). From 2014 to 2022 he was founding Editor-in-Chief of the open access journal ESC Heart Failure. He was member of several ESC Guideline groups (e.g. for Heart Failure in 2012 & 2016). Dr. Anker is the President of the International Society on Sarcopenia, Cachexia and Wasting Disorders since 2008 (SCWD – see www.cachexia.org). Dr. Anker is founding Editor-in-Chief of the Journal of Cachexia, Sarcopenia and Muscle since 2010 (JCSM, 2023-IF: 9.4, see www.jcsm.info). Dr. Anker was and is member of >30 international clinical trial steering committees, chairing or co-chairing several (incl. FAIR-HF2 [JAMA’25], RESHAPE-HF2 [NEJM’24], EMPEROR-Preserved [NEJM’21], FAIR-HF [NEJM’09], RELIEVE-HF, DIAMOND-HF, TIM-HF, ACT-ONE, AUGMENT-HF & BACH). https://www.biomarkersmeeting.com/madsen daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/18cf5a4c-c0d1-4f5d-a3b0-0bafef345539/Christian+Toft+Madsen.jpg Madsen - Christian Toft MADSEN, Novo Nordisk, Denmark Christian Toft Madsen has a scientific background as Molecular biologist with broad experience within RNA biochemistry and virology, RNA interference mechanisms, yeast genetics and mass spectrometry-based proteomics. Over the past 10 years, he has been instrumental in establishing Peptidomics as a cutting-edge target discovery discipline and a biomarker tool at Novo Nordisk. Christian has a unique ability to integrate technology and biology, and he is deeply passionate about uncovering novel biological mechanisms in the projects he works on. He is a well-liked and respected integral member of the Global Translation team in Novo Nordisk, driving innovation initiatives across R&ED and fostering collaboration across global sites. https://www.biomarkersmeeting.com/genovese daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/38138384-4155-4d8a-89b7-1c3b234843ad/AR1_3164.jpg Genovese - Federica GENOVESE, Nordic Bioscience, Denmark Federica Genovese works as Director of Cardiovascular and Kidney Research at Nordic Bioscience (Denmark), a biomarker company leader in extracellular matrix research. Her research revolves around the application of markers of extracellular matrix remodeling in fibrotic diseases of the heart and the kidneys. During her 14 years tenure she has led a team focused on the discovery, development of validation of several biomarkers of tissue turnover, which resulted in more than 100 peer-reviewed publications. https://www.biomarkersmeeting.com/azibani daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/38ec1d11-79d3-44aa-84fd-eb89f44ea7c3/Photo_Feriel+Azibani.jpg Azibani - Feriel AZIBANI - Paris, France As a basic scientist and researcher, my primary focus lies in the physiopathology of cardiac dysfunction within circulatory diseases, including septic and cardiogenic shock. I have a strong interest in the endocrine system and cell signaling pathways within the cardiac and vascular compartments. My ongoing and future projects aim to better characterize cardio-circulatory failure, elucidate the pathophysiology of vasoplegia and cardiac dysfunction, and explore the immune alterations that lead to organ failure. I also have a great interest in acute heart failure including pregnancy diseases and cardio-oncology. A major goal of my work is to provide critical insights into disease mechanisms and conduct preclinical evaluations of novel drug therapies or drug combinations, which are essential for advancing to First-in-Human and Phase II clinical trials. In 2022, I was awarded a highly competitive permanent research position at Inserm, where I now lead a research team focused on identifying bio-targets in cardio-circulatory failure. https://www.biomarkersmeeting.com/dronkers daily 0.75 2025-04-22 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/9a138115-d22e-4ef5-8aed-7ee085ff8622/Biomarker_meeting_Photo_JustDronkers.jpg Dronkers - Just DRONKERS - Groningen, Netherlands Just Dronkers completed his Master's degree in Biomedical Sciences at the University of Groningen in 2017. During his studies, he developed a strong interest in cardiology through an internship in experimental cardiology. After graduation, he pursued a career as a professional volleyball player, competing in Belgium and for the Dutch national team. In 2022, he decided to return to science and rejoined the cardiology department. His current research focuses on the underlying mechanisms of metabolic dysfunction and heart failure, with a particular interest in the role of adipose tissue. https://www.biomarkersmeeting.com/ouwerkerk daily 0.75 2025-04-25 https://images.squarespace-cdn.com/content/v1/5c3c7e1a4cde7af56b508139/45c21901-1a26-4f62-86ba-89f56f2be533/IMG_0035.jpg Wouter Ouwerkerk - Wouter OUWERKERK, Amsterdam, Netherlands Wouter Ouwerkerk is an enthusiastic researcher trained in biostatistics, bioinformatics and genetic epidemiology, actively conducting research in the fields of cardiology, dermatology and cancer-immunology. Wouter is bridging these fields by effectively combining expertise from both fields to achieve high-impact multidisciplinary research. His research is focussed on personalised treatment and systems medicine, using multi-omics high-dimensional data. After successfully completing his PhD he started his post-doctoral research at the dept. dermatology. Here, he build a world-wide consortium to study genetic susceptibility of response to immunotherapy in melanoma patients. At the same time at the National Heart Centre Singapore he continued to pursue his interests in personalised treatment and systems medicine in cardiovascular disease, using high-dimensional data and large observational cohorts.